Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124209
Circumventing Antivector Immunity: Potential Use Of Nonhuman Adenoviral Vectors
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Adenoviruses are efficient gene delivery vectors based on their ability to transduce a wide variety of cell types and drive high-level transient transgene expression. While there have been advances in modifying human adenoviral (HAdV) vectors to increase their safety profile, there are still pitfalls that need to be further addressed. Preexisting humoral and cellular immunity against common HAdV serotypes limits the efficacy of gene transfer and duration of transgene expression. As an alternative, nonhuman AdV (NHAdV) vectors can circumvent neutralizing antibodies against HAdVs in immunized mice and monkeys and in human sera, suggesting that NHAdV vectors could circumvent preexisting humoral immunity against HAdVs in a clinical setting. Consequently, there has been an increased interest in developing NHAdV vectors for gene delivery in humans. In this review, we outline the recent advances and limitations of HAdV vectors for gene therapy and describe examples of NHAdV vectors focusing on their immunogenicity, tropism, and potential as effective gene therapy vehicles.
Matèries
Matèries (anglès)
Citació
Citació
LÓPEZ GORDO, Estrella, PODGORSKI, Iva i., DOWNES, Nicholas, ALEMANY BONASTRE, Ramon. Circumventing Antivector Immunity: Potential Use Of Nonhuman Adenoviral Vectors. _Human Gene Therapy_. 2014. Vol. 25, núm. 4, pàgs. 285-300. [consulta: 24 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/124209]